A 28-year-old female with a family history of anesthetic complications undergoes preoperative screening. Genetic testing confirms a mutation in the RYR1 gene. Which clinical or laboratory finding best distinguishes her risk for malignant hyperthermia from that of a patient with central core disease (CCD)?